This document is an excerpt from the EUR-Lex website
Document 32010R1238
Regulation (EU) No 1238/2010 of the European Parliament and of the Council of 15 December 2010 amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
Regolament (UE) Nru 1238/2010 tal-Parlament Ewropew u tal-Kunsill tal- 15 ta' Diċembru 2010 li jemenda l-Anness I tar-Regolament tal-Kunsill (KEE) Nru 2658/87 f'dak li huwa l-forniment ta' trattament mingħajr dazju għal ingredjenti attivi farmaċewtiċi speċifikati li għandhom “isem komuni internazzjonali” (INN) mill-Organizzazzjoni Dinjija tas-Saħħa u prodotti speċifikati użati għall-manifattura ta' sustanzi farmaċewtiċi lesti
Regolament (UE) Nru 1238/2010 tal-Parlament Ewropew u tal-Kunsill tal- 15 ta' Diċembru 2010 li jemenda l-Anness I tar-Regolament tal-Kunsill (KEE) Nru 2658/87 f'dak li huwa l-forniment ta' trattament mingħajr dazju għal ingredjenti attivi farmaċewtiċi speċifikati li għandhom “isem komuni internazzjonali” (INN) mill-Organizzazzjoni Dinjija tas-Saħħa u prodotti speċifikati użati għall-manifattura ta' sustanzi farmaċewtiċi lesti
ĠU L 348, 31.12.2010, p. 36–73
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
- Date of document:
- 15/12/2010
- Date of effect:
- 01/01/2011; Dħul fis-seħħ Data tal-pubblikazzjoni +1 Ara Art. 2
- Date of effect:
- 01/01/2011; Applikazzjoni Ara Art. 2
- Date of end of validity:
- No end date
- Author:
- Il-Parlament Ewropew, Il-Kunsill tal-Unjoni Ewropea
- Form:
- Regolament
- Procedure number:
- Link
- European Parliament - Legislative observatory
- Treaty:
- Trattat dwar il-Funzjonament tal-Unjoni Ewropea
- Legal basis:
- Proposal:
- Link
- Link
- Link
- Link
- Link
- Select all documents mentioning this document No data available in the table
- Modifies:
-
Relation Act Comment Subdivision concerned From To Modifies 31987R2658 Emenda anness I 01/01/2011 - Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
|
31.12.2010 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
L 348/36 |
REGOLAMENT (UE) Nru 1238/2010 TAL-PARLAMENT EWROPEW U TAL-KUNSILL
tal-15 ta' Diċembru 2010
li jemenda l-Anness I tar-Regolament tal-Kunsill (KEE) Nru 2658/87 f'dak li huwa l-forniment ta' trattament mingħajr dazju għal ingredjenti attivi farmaċewtiċi speċifikati li għandhom “isem komuni internazzjonali” (INN) mill-Organizzazzjoni Dinjija tas-Saħħa u prodotti speċifikati użati għall-manifattura ta' sustanzi farmaċewtiċi lesti
IL-PARLAMENT EWROPEW U L-KUNSILL TAL-UNJONI EWROPEA,
Wara li kkunsidraw it-Trattat dwar il-Funzjonament tal-Unjoni Ewropea, u b’mod partikolari l-Artikolu 207 tiegħu,
Wara li kkunsidraw il-proposta mill-Kummissjoni Ewropea,
Wara l-preżentazzjoni tal-abbozz tal-att leġislattiv lill-parlamenti nazzjonali,
Filwaqt li jaġixxu skont il-proċedura leġislattiva ordinarja (1),
Billi:
|
(1) |
Matul in-negozjati tal-Uruguay Round, il-Komunità u għadd ta' pajjiżi qablu li għandu jingħata trattament mingħajr dazju għal prodotti farmaċewtiċi li jaqgħu taħt is-Sistema Armonizzata (SA) il-Kapitolu 30 u l-intestaturi SA 2936, 2937, 2939 u 2941, kif ukoll għal ingredjenti attivi farmaċewtiċi speċifiċi li għandhom “isem komuni internazzjonali” (INN) mill-Organizzazzjoni Dinjija tas-Saħħa, imluħa, esteri u idrati speċifiċi ta' tali INNs, u intermedjarji farmaċewtiċi speċifiċi użati għall-produzzjoni u l-manifattura ta' prodotti farmaċewtiċi lesti. |
|
(2) |
Ir-riżultati tad-diskussjonijiet, kif stipulati fir-Reġistru tad-Diskussjonijiet, ġew inkorporati fl-iskedi tat-tariffi tal-parteċipanti annessi għall-Protokoll ta' Marrakesh għall-Ftehim Ġenerali dwar it-Tariffi u l-Kummerċ (GATT) 1994. |
|
(3) |
Il-parteċipanti kkonkludew li r-rappreżentanti tal-membri tal-Organizzazzjoni Dinjija tal-Kummerċ (WTO), li huma parti għar-Reġistru tad-Diskussjonijiet, għandhom jiltaqgħu taħt l-awspiċi tal-Kunsill tad-WTO għall-Kummerċ ta' Oġġetti, normalment darba kull tliet snin, biex jevalwaw il-kopertura tal-prodotti bil-ħsieb li jinkludu, b’kunsens, prodotti farmaċewtiċi addizzjonali għat-tneħħija tat-tariffa. |
|
(4) |
Saru tliet evalwazzjonijiet minn dawn bir-riżultat li ngħata trattament mingħajr dazju għal għadd ta' INNs addizzjonali u intermedjarji farmaċewtiċi użati għall-produzzjoni u l-manifattura ta' prodotti farmaċewtiċi lesti, li wħud minn dawk l-intermedjarji ġew ittrasferiti għal-lista ta' INNs, u li l-lista ta' prefissi u suffissi speċifiċi għal imluħa, esteri jew idrati tal-INNs ġiet estiża. |
|
(5) |
Tqies li jkun xieraq li ssir ir-raba’ evalwazzjoni, u din tnediet fl-2009. Din l-evalwazzjoni kkonkludiet li għandu jingħata trattament mingħajr dazju għal għadd ta' INNs addizzjonali u intermedjarji farmaċewtiċi użati għall-produzzjoni u l-manifattura ta' farmaċewtiċi lesti, li wħud minn dawk l-intermedjarji li diġà ġew inklużi fl-arranġament settorjali farmaċewtiku u r-reviżjonijiet tiegħu għandhom jiġu trasferiti għal-lista tal-INNs, u li l-lista ta' prefissi u suffissi speċifiċi għal imluħa, esteri u idrati tal-INNs għandha tiġi estiża. |
|
(6) |
Ir-Regolament tal-Kunsill (KEE) Nru 2658/87 tat-23 ta' Lulju 1987 dwar in-nomenklatura tat-tariffa u l-istatistika u dwar it-Tariffa Doganali Komuni (2) stabbilixxa n-Nomenklatura Magħquda (NM) u stabbilixxa r-rati konvenzjonali tad-dazju tat-Tariffa Doganali Komuni. |
|
(7) |
Ir-Regolament (KEE) Nru 2658/87 għandu għaldaqstant jiġi emendat kif meħtieġ. |
|
(8) |
Sabiex ikun żgurat li l-miżuri previsti f’dan ir-Regolament japplikaw mill-1 ta' Jannar 2011, huwa għandu jidħol fis-seħħ fil-jum ta' wara dak tal-pubblikazzjoni tiegħu, |
ADOTTAW DAN IR-REGOLAMENT:
Artikolu 1
L-Annessi 3, 4 u 6 tat-Taqsima II tal-Parti Tlieta tal-Anness I għar-Regolament (KEE) Nru 2658/87 (Listi ta' sustanzi farmaċewtiċi li jikkwalifikaw għal-trattament mingħajr dazju) huma b'dan emendati kif ġej:
|
(1) |
Mill-1 ta' Jannar 2011, l-Unjoni għandha testendi t-trattament mingħajr dazju għall-INNs elenkati fl-Anness I. |
|
(2) |
Mill-1 ta' Jannar 2011, il-lista ta' prefissi u suffissi li, f’kombinazzjoni mal-INNs inklużi fl-arranġament settorjali farmaċewtiku u r-reviżjonijiet tiegħu, jiddeskrivu l-imluħa, l-esteri jew l-idrati tal-INNs li huma eliġibbli wkoll għal trattament mingħajr dazju, bil-kondizzjoni li dawn ikunu klassifikabbli fl-istess subintestatura tas-SA ta' sitt ċifri bħall-INN korrespondenti, għandha tiġi emendata kif stabbilit fl-Anness II. |
|
(3) |
Mill-1 ta' Jannar 2011, l-Unjoni għandha testendi t-trattament mingħajr dazju għall-intermedjarji farmaċewtiċi użati fil-produzzjoni u l-manifattura ta' farmaċewtiċi lesti elenkati fl-Anness III. |
|
(4) |
Mill-1 ta' Jannar 2011, l-intermedjarji farmaċewtiċi elenkati fl-Anness IV għandhom jiġu rtirati mil-lista ta' dawn il-kompożizzjonijiet li jirċievu trattament mingħajr dazju. |
Artikolu 2
Dan ir-Regolament għandu jidħol fis-seħħ l-għada tal-pubblikazzjoni tiegħu f'Il-Ġurnal Uffiċjali tal-Unjoni Ewropea.
Għandu japplika mill-1 ta' Jannar 2011.
Dan ir-Regolament għandu jorbot fl-intier tiegħu u japplika direttament fl-Istati Membri kollha.
Magħmul fi Strasburgu, il-15 ta’ Diċembru 2010
Għall-Parlament Ewropew
Il-President
J. BUZEK
Għall-Kunsill
Il-President
O. CHASTEL
(1) Pożizzjoni tal-Parlament Ewropew tat-23 ta' Novembru 2010 (għadha mhijiex ippubblikata fil-Ġurnal Uffiċjali) u deċiżjoni tal-Kunsill tal-10 ta' Diċembru 2010.
ANNESS I
Lista ta’ ismijiet komuni internazzjonali (INNs) li għandhom jiżdiedu mal-lista ta’ prodotti li jirċievu trattament mingħajr dazju inkluża fl-Anness 3 għall-Anness I għar-Regolament (KEE) Nru 2658/87
|
Kodiċi NM |
CAS RN |
Isem |
|
2842 90 80 |
119175-48-3 |
fermagate |
|
2843 90 90 |
759457-82-4 |
padeliporfin |
|
2844 40 30 |
123748-56-1 |
iodofiltic acid (
|
|
2904 10 00 |
21668-77-9 |
eprodisate |
|
2906 19 00 |
199798-84-0 |
elocalcitol |
|
2909 30 90 |
24150-24-1 |
terameprocol |
|
2916 19 95 |
81485-25-8 |
peretinoin |
|
2916 39 00 |
51543-40-9 |
tarenflurbil |
|
2918 19 98 |
174022-42-5 |
bevirimat |
|
2919 90 00 |
258516-89-1 |
fospropofol |
|
2920 90 85 |
163133-43-5 |
naproxcinod |
|
2921 19 99 |
3687-18-1 |
tramiprosate |
|
2922 19 85 |
68392-35-8 |
afimoxifene |
|
2922 19 85 |
753449-67-1 |
ronacaleret |
|
2922 29 00 |
433265-65-7 |
faxeladol |
|
2922 50 00 |
121524-08-1 |
amibegron |
|
2922 50 00 |
329773-35-5 |
cinaciguat |
|
2922 50 00 |
643094-49-9 |
fasobegron |
|
2923 10 00 |
856676-23-8 |
choline fenofibrate |
|
2924 29 98 |
847353-30-4 |
arbaclofen placarbil |
|
2924 29 98 |
194785-19-8 |
bedoradrine |
|
2924 29 98 |
194085-75-1 |
carisbamate |
|
2924 29 98 |
254750-02-2 |
emricasan |
|
2924 29 98 |
355129-15-6 |
eprotirome |
|
2924 29 98 |
402567-16-2 |
firategrast |
|
2924 29 98 |
478296-72-9 |
gabapentin enacarbil |
|
2924 29 98 |
15866-90-7 |
incyclinide |
|
2924 29 98 |
202844-10-8 |
indantadol |
|
2924 29 98 |
96847-55-1 |
levomilnacipran |
|
2924 29 98 |
608137-32-2 |
lisdexamfetamine |
|
2924 29 98 |
652990-07-3 |
milveterol |
|
2924 29 98 |
181816-48-8 |
ombrabulin |
|
2924 29 98 |
289656-45-7 |
senicapoc |
|
2925 19 95 |
19171-19-8 |
pomalidomide |
|
2928 00 90 |
22033-87-0 |
olesoxime |
|
2928 00 90 |
2675-35-6 |
sivifene |
|
2928 00 90 |
816458-31-8 |
tecovirimat |
|
2928 00 90 |
238750-77-1 |
tosedostat |
|
2928 00 90 |
149647-78-9 |
vorinostat |
|
2929 90 00 |
31645-39-3 |
palifosfamide |
|
2930 90 99 |
608141-41-9 |
apremilast |
|
2930 90 99 |
216167-92-9 |
camobucol |
|
2930 90 99 |
211513-37-0 |
dalcetrapib |
|
2930 90 99 |
69819-86-9 |
darinaparsin |
|
2930 90 99 |
488832-69-5 |
elesclomol |
|
2930 90 99 |
216167-95-2 |
elsibucol |
|
2930 90 99 |
168682-53-9 |
ezatiostat |
|
2930 90 99 |
58569-55-4 |
metenkefalin |
|
2930 90 99 |
887148-69-8 |
monepantel |
|
2930 90 99 |
603139-19-1 |
odanacatib |
|
2930 90 99 |
162520-00-5 |
salirasib |
|
2930 90 99 |
216167-82-7 |
succinobucol |
|
2930 90 99 |
125961-82-2 |
tipelukast |
|
2931 00 99 |
125973-56-0 |
amsilarotene |
|
2932 19 00 |
253128-41-5 |
eribulin |
|
2932 19 00 |
186953-56-0 |
pafuramidine |
|
2932 29 85 |
195883-06-8 |
omtriptolide |
|
2932 99 00 |
664338-39-0 |
arterolane |
|
2932 99 00 |
183133-96-2 |
cabazitaxel |
|
2932 99 00 |
401925-43-7 |
celivarone |
|
2932 99 00 |
461432-26-8 |
dapagliflozin |
|
2932 99 00 |
118457-15-1 |
dexnebivolol |
|
2932 99 00 |
156294-36-9 |
larotaxel |
|
2932 99 00 |
118457-16-2 |
levonebivolol |
|
2932 99 00 |
83461-56-7 |
mifamurtide |
|
2932 99 00 |
117570-53-3 |
vadimezan |
|
2933 19 90 |
496775-61-2 |
eltrombopag |
|
2933 19 90 |
206884-98-2 |
niraxostat |
|
2933 19 90 |
410528-02-8 |
palovarotene |
|
2933 19 90 |
376592-42-6 |
totrombopag |
|
2933 29 90 |
183659-72-5 |
catramilast |
|
2933 29 90 |
944263-65-4 |
demiditraz |
|
2933 29 90 |
867153-61-5 |
dulanermin |
|
2933 29 90 |
320367-13-3 |
lixisenatide |
|
2933 29 90 |
698389-00-3 |
rolipoltide |
|
2933 29 90 |
697766-75-9 |
velafermin |
|
2933 39 99 |
147084-10-4 |
alcaftadine |
|
2933 39 99 |
54-96-6 |
amifampridine |
|
2933 39 99 |
249921-19-5 |
anamorelin |
|
2933 39 99 |
319460-85-0 |
axitinib |
|
2933 39 99 |
208110-64-9 |
befiradol |
|
2933 39 99 |
330942-05-7 |
betrixaban |
|
2933 39 99 |
201034-75-5 |
daporinad |
|
2933 39 99 |
209783-80-2 |
entinostat |
|
2933 39 99 |
412950-27-7 |
goxalapladib |
|
2933 39 99 |
218791-21-0 |
imisopasem manganese |
|
2933 39 99 |
103129-82-4 |
levamlodipine |
|
2933 39 99 |
154357-42-3 |
levonadifloxacin |
|
2933 39 99 |
108147-54-2 |
migalastat |
|
2933 39 99 |
453562-69-1 |
motesanib |
|
2933 39 99 |
139145-27-0 |
parogrelil |
|
2933 39 99 |
459856-18-9 |
pexacerfont |
|
2933 39 99 |
706779-91-1 |
pimavanserin |
|
2933 39 99 |
362665-56-3 |
pitolisant |
|
2933 39 99 |
861151-12-4 |
rosonabant |
|
2933 39 99 |
701977-09-5 |
taranabant |
|
2933 39 99 |
189950-11-6 |
tropantiol |
|
2933 39 99 |
793655-64-8 |
vapitadine |
|
2933 39 99 |
139290-65-6 |
volinaserin |
|
2933 49 90 |
141388-76-3 |
besifloxacin |
|
2933 49 90 |
697761-98-1 |
elvitegravir |
|
2933 49 90 |
185055-67-8 |
ferroquine |
|
2933 49 90 |
445041-75-8 |
intiquinatine |
|
2933 49 90 |
378746-64-6 |
nemonoxacin |
|
2933 49 90 |
245765-41-7 |
ozenoxacin |
|
2933 49 90 |
412950-08-4 |
rilapladib |
|
2933 49 90 |
871224-64-5 |
almorexant |
|
2933 49 90 |
863029-99-6 |
balamapimod |
|
2933 49 90 |
698387-09-6 |
neratinib |
|
2933 49 90 |
154652-83-2 |
tezampanel |
|
2933 49 90 |
128253-31-6 |
veliflapon |
|
2933 59 95 |
791828-58-5 |
aderbasib |
|
2933 59 95 |
840486-93-3 |
adipiplon |
|
2933 59 95 |
850649-61-5 |
alogliptin |
|
2933 59 95 |
859212-16-1 |
bafetinib |
|
2933 59 95 |
380843-75-4 |
bosutinib |
|
2933 59 95 |
839712-12-8 |
cariprazine |
|
2933 59 95 |
414910-27-3 |
casopitant |
|
2933 59 95 |
288383-20-0 |
cediranib |
|
2933 59 95 |
849550-05-6 |
cevipabulin |
|
2933 59 95 |
827318-97-8 |
danusertib |
|
2933 59 95 |
356057-34-6 |
darapladib |
|
2933 59 95 |
501000-36-8 |
dutacatib |
|
2933 59 95 |
247257-48-3 |
fimasartan |
|
2933 59 95 |
3432-99-3 |
folitixorin |
|
2933 59 95 |
668270-12-0 |
linagliptin |
|
2933 59 95 |
441798-33-0 |
macitentan |
|
2933 59 95 |
641571-10-0 |
nilotinib |
|
2933 59 95 |
763113-22-0 |
olaparib |
|
2933 59 95 |
686344-29-6 |
otenabant |
|
2933 59 95 |
625115-55-1 |
riociguat |
|
2933 59 95 |
486460-32-6 |
sitagliptin |
|
2933 59 95 |
425637-18-9 |
sotrastaurin |
|
2933 59 95 |
309913-83-5 |
talmapimod |
|
2933 59 95 |
113857-87-7 |
talotrexin |
|
2933 59 95 |
274693-27-5 |
ticagrelor |
|
2933 59 95 |
306296-47-9 |
vicriviroc |
|
2933 69 80 |
775351-65-0 |
imeglimin |
|
2933 79 00 |
461443-59-4 |
aplaviroc |
|
2933 79 00 |
189691-06-3 |
bremelanotide |
|
2933 79 00 |
813452-18-5 |
carmegliptin |
|
2933 79 00 |
405169-16-6 |
dovitinib |
|
2933 79 00 |
536748-46-6 |
eribaxaban |
|
2933 79 00 |
473289-62-2 |
ilepatril |
|
2933 79 00 |
180694-97-7 |
mimopezil |
|
2933 79 00 |
579475-18-6 |
orvepitant |
|
2933 79 00 |
449811-01-2 |
pamapimod |
|
2933 79 00 |
248282-01-1 |
paquinimod |
|
2933 79 00 |
380917-97-5 |
perampanel |
|
2933 79 00 |
552292-08-7 |
rolapitant |
|
2933 79 00 |
425386-60-3 |
semagacestat |
|
2933 79 00 |
515814-01-4 |
voclosporin |
|
2933 99 80 |
481629-87-2 |
aleplasinin |
|
2933 99 80 |
394730-60-0 |
boceprevir |
|
2933 99 80 |
649735-63-7 |
brivanib alaninate |
|
2933 99 80 |
483369-58-0 |
denagliptin |
|
2933 99 80 |
284019-34-7 |
denibulin |
|
2933 99 80 |
481631-45-2 |
diaplasinin |
|
2933 99 80 |
272105-42-7 |
disitertide |
|
2933 99 80 |
227318-71-0 |
epetirimod |
|
2933 99 80 |
259793-96-9 |
favipiravir |
|
2933 99 80 |
871576-03-3 |
flovagatran |
|
2933 99 80 |
229305-39-9 |
golotimod |
|
2933 99 80 |
258818-34-7 |
larazotide |
|
2933 99 80 |
571170-77-9 |
laropiprant |
|
2933 99 80 |
616202-92-7 |
lorcaserin |
|
2933 99 80 |
868771-57-7 |
melogliptin |
|
2933 99 80 |
803712-67-6 |
obatoclax |
|
2933 99 80 |
404950-80-7 |
panobinostat |
|
2933 99 80 |
625114-41-2 |
piragliatin |
|
2933 99 80 |
74847-35-1 |
pyronaridine |
|
2933 99 80 |
872178-65-9 |
rabeximod |
|
2933 99 80 |
355151-12-1 |
rotigaptide |
|
2933 99 80 |
497221-38-2 |
rusalatide |
|
2933 99 80 |
187602-11-5 |
sofigatran |
|
2933 99 80 |
227318-75-4 |
sotirimod |
|
2933 99 80 |
402957-28-2 |
telaprevir |
|
2933 99 80 |
848084-83-3 |
tigapotide |
|
2933 99 80 |
393105-53-8 |
tiplasinin |
|
2933 99 80 |
620948-93-8 |
vabicaserin |
|
2933 99 80 |
794466-70-9 |
vernakalant |
|
2934 10 00 |
544417-40-5 |
capadenoson |
|
2934 10 00 |
302962-49-8 |
dasatinib |
|
2934 10 00 |
223132-37-4 |
inolitazone |
|
2934 10 00 |
241479-67-4 |
isavuconazole |
|
2934 10 00 |
338990-84-4 |
isavuconazonium chloride |
|
2934 10 00 |
607723-33-1 |
lobeglitazone |
|
2934 10 00 |
280782-97-0 |
managlinat dialanetil |
|
2934 10 00 |
790299-79-5 |
masitinib |
|
2934 10 00 |
223673-61-8 |
mirabegron |
|
2934 10 00 |
501948-05-6 |
rosabulin |
|
2934 10 00 |
447406-78-2 |
sodelglitazar |
|
2934 10 00 |
760937-92-6 |
teneligliptin |
|
2934 20 80 |
848344-36-5 |
bentamapimod |
|
2934 20 80 |
870093-23-5 |
talarozole |
|
2934 99 90 |
320345-99-1 |
aclidinium bromide |
|
2934 99 90 |
222551-17-9 |
adoprazine |
|
2934 99 90 |
207623-20-9 |
agatolimod |
|
2934 99 90 |
475479-34-6 |
aleglitazar |
|
2934 99 90 |
870524-46-2 |
amolimogene bepiplasmid |
|
2934 99 90 |
875446-37-0 |
anacetrapib |
|
2934 99 90 |
250386-15-3 |
apadenoson |
|
2934 99 90 |
541550-19-0 |
apilimod |
|
2934 99 90 |
160707-69-7 |
apricitabine |
|
2934 99 90 |
147403-03-0 |
azilsartan |
|
2934 99 90 |
863031-21-4 |
azilsartan medoxomil |
|
2934 99 90 |
757942-43-1 |
bederocin |
|
2934 99 90 |
627861-07-8 |
beperminogene perplasmid |
|
2934 99 90 |
959961-96-7 |
bevasiranib |
|
2934 99 90 |
769901-96-4 |
capeserod |
|
2934 99 90 |
868540-17-4 |
carfilzomib |
|
2934 99 90 |
872847-66-0 |
cenersen |
|
2934 99 90 |
80295-38-1 |
conestat alfa |
|
2934 99 90 |
903916-27-8 |
custirsen |
|
2934 99 90 |
187865-22-1 |
derquantel |
|
2934 99 90 |
134379-77-4 |
dexelvucitabine |
|
2934 99 90 |
247046-52-2 |
dilopetine |
|
2934 99 90 |
480449-70-5 |
edoxaban |
|
2934 99 90 |
188181-42-2 |
elacytarabine |
|
2934 99 90 |
98819-76-2 |
esreboxetine |
|
2934 99 90 |
763903-67-9 |
fosalvudine tidoxil |
|
2934 99 90 |
172673-20-0 |
fosaprepitant |
|
2934 99 90 |
522664-63-7 |
ibodutant |
|
2934 99 90 |
405159-59-3 |
idrabiotaparinux sodium |
|
2934 99 90 |
188116-07-6 |
imepitoin |
|
2934 99 90 |
335619-18-6 |
inakalant |
|
2934 99 90 |
1391-36-2 |
lancovutide |
|
2934 99 90 |
189059-71-0 |
lapaquistat |
|
2934 99 90 |
327026-93-7 |
lensiprazine |
|
2934 99 90 |
170632-47-0 |
lificiguat |
|
2934 99 90 |
852313-25-8 |
litenimod |
|
2934 99 90 |
1000120-98-8 |
mipomersen |
|
2934 99 90 |
62253-63-8 |
nepidermin |
|
2934 99 90 |
26833-87-4 |
omacetaxine mepesuccinate |
|
2934 99 90 |
269718-84-5 |
pardoprunox |
|
2934 99 90 |
219923-85-0 |
pramiconazole |
|
2934 99 90 |
377727-87-2 |
preladenant |
|
2934 99 90 |
524684-52-4 |
prinaberel |
|
2934 99 90 |
865311-47-3 |
quarfloxin |
|
2934 99 90 |
869884-78-6 |
radezolid |
|
2934 99 90 |
496054-87-6 |
radiprodil |
|
2934 99 90 |
518048-05-0 |
raltegravir |
|
2934 99 90 |
787548-03-2 |
regrelor |
|
2934 99 90 |
820957-38-8 |
retosiban |
|
2934 99 90 |
572924-54-0 |
ridaforolimus |
|
2934 99 90 |
128517-07-7 |
romidepsin |
|
2934 99 90 |
93265-81-7 |
ropidoxuridine |
|
2934 99 90 |
151823-14-2 |
sapacitabine |
|
2934 99 90 |
379231-04-6 |
saracatinib |
|
2934 99 90 |
791635-59-1 |
simotaxel |
|
2934 99 90 |
119567-79-2 |
taribavirin |
|
2934 99 90 |
332012-40-5 |
telatinib |
|
2934 99 90 |
925681-61-4 |
trabedersen |
|
2934 99 90 |
189003-92-7 |
trelanserin |
|
2934 99 90 |
296251-72-4 |
velimogene aliplasmid |
|
2934 99 90 |
904302-98-3 |
viquidacin |
|
2934 99 90 |
872525-61-6 |
votucalis |
|
2934 99 90 |
221877-54-9 |
zotarolimus |
|
2935 00 90 |
197904-84-0 |
apricoxib |
|
2935 00 90 |
769169-27-9 |
begacestat |
|
2935 00 90 |
414864-00-9 |
belinostat |
|
2935 00 90 |
313682-08-5 |
brecanavir |
|
2935 00 90 |
839673-52-8 |
cevoglitazar |
|
2935 00 90 |
358970-97-5 |
drinabant |
|
2935 00 90 |
865200-20-0 |
giripladib |
|
2935 00 90 |
464213-10-3 |
ibipinabant |
|
2935 00 90 |
173424-77-6 |
laromustine |
|
2935 00 90 |
398507-55-6 |
lodenafil carbonate |
|
2935 00 90 |
136564-68-6 |
masilukast |
|
2935 00 90 |
170569-88-7 |
mavacoxib |
|
2935 00 90 |
862189-95-5 |
mirodenafil |
|
2935 00 90 |
439687-69-1 |
nelivaptan |
|
2935 00 90 |
691852-58-1 |
nesbuvir |
|
2935 00 90 |
778576-62-8 |
oglemilast |
|
2935 00 90 |
444731-52-6 |
pazopanib |
|
2935 00 90 |
362505-84-8 |
relacatib |
|
2935 00 90 |
243984-11-4 |
resatorvid |
|
2935 00 90 |
519055-62-0 |
tasisulam |
|
2935 00 90 |
186497-07-4 |
zibotentan |
|
2936 29 00 |
104121-92-8 |
eldecalcitol |
|
2936 29 00 |
31690-09-2 |
levomefolic acid |
|
2937 19 00 |
782500-75-8 |
albiglutide |
|
2937 19 00 |
348119-84-6 |
obinepitide |
|
2937 19 00 |
295350-45-7 |
ozarelix |
|
2937 19 00 |
275371-94-3 |
taspoglutide |
|
2937 19 00 |
218949-48-5 |
tesamorelin |
|
2937 19 00 |
22006-64-0 |
tridecactide |
|
2937 22 00 |
132245-57-9 |
dexamethasone cipecilate |
|
2937 22 00 |
397864-44-7 |
fluticasone furoate |
|
2937 29 00 |
211254-73-8 |
lonaprisan |
|
2937 50 00 |
333963-42-1 |
cobiprostone |
|
2937 50 00 |
172740-14-6 |
posaraprost |
|
2937 90 00 |
834153-87-6 |
elagolix |
|
2937 90 00 |
609799-22-6 |
tasimelteon |
|
2937 90 00 |
342577-38-2 |
velneperit |
|
2939 19 00 |
73232-52-7 |
methylnaltrexone bromide |
|
2939 59 00 |
136199-02-5 |
rolofylline |
|
2939 99 00 |
850607-58-8 |
darotropium bromide |
|
2939 99 00 |
187852-63-7 |
delimotecan |
|
2940 00 00 |
9007-72-1 |
ferric carboxymaltose |
|
2940 00 00 |
442201-24-3 |
remogliflozin etabonate |
|
2940 00 00 |
408504-26-7 |
sergliflozin etabonate |
|
2941 90 00 |
467214-20-6 |
alvespimycin |
|
2941 90 00 |
677017-23-1 |
berubicin |
|
2941 90 00 |
229016-73-3 |
ceftaroline fosamil |
|
2941 90 00 |
318498-76-9 |
flopristin |
|
2941 90 00 |
145435-72-9 |
gamithromycin |
|
2941 90 00 |
325965-23-9 |
linopristin |
|
2941 90 00 |
857402-23-4 |
retaspimycin |
|
2941 90 00 |
305841-29-6 |
sagopilone |
|
2941 90 00 |
75747-14-7 |
tanespimycin |
|
2941 90 00 |
328898-40-4 |
tildipirosin |
|
2941 90 00 |
222400-20-6 |
tomopenem |
|
2941 90 00 |
63409-12-1 |
tylvalosin |
|
3001 90 91 |
9041-08-1 |
semuloparin sodium |
|
3002 10 91 |
792921-10-9 |
abagovomab |
|
3002 10 91 |
910649-32-0 |
anrukinzumab |
|
3002 10 91 |
648904-28-3 |
bavituximab |
|
3002 10 91 |
402710-27-4 (katina ħafifa) 402710-25-2 (katina tqila) |
canakinumab |
|
3002 10 99 |
945228-49-9 |
citatuzumab bogatox |
|
3002 10 91 |
880486-59-9 |
dacetuzumab |
|
3002 10 91 |
615258-40-7 |
denosumab |
|
3002 10 91 |
762260-74-2 |
efungumab |
|
3002 10 91 |
89957-37-9 |
gantenerumab |
|
3002 10 91 |
680188-33-4 |
ibalizumab |
|
3002 10 91 |
477202-00-9 |
ipilimumab |
|
3002 10 91 |
640735-09-7 |
iratumumab |
|
3002 10 91 |
845816-02-6 |
lexatumumab |
|
3002 10 91 |
903512-50-5 |
lucatumumab |
|
3002 10 91 |
899796-83-9 |
milatuzumab |
|
3002 10 91 |
677010-34-3 |
motavizumab |
|
3002 10 91 |
676258-98-3 |
naptumomab estafenatox |
|
3002 10 91 |
828933-51-3 |
nimotuzumab |
|
3002 10 91 |
949142-50-1 |
obinutuzumab |
|
3002 10 91 |
637334-45-3 |
ocrelizumab |
|
3002 10 91 |
881191-44-2 |
otelixizumab |
|
3002 10 91 |
372075-37-1 |
sontuzumab |
|
3002 10 91 |
705287-60-1 |
stamulumab |
|
3002 10 91 |
339086-80-5 |
tadocizumab |
|
3002 10 91 |
592557-43-2 (katina tqila) 592557-41-0 (katina ħafifa) |
tenatumomab |
|
3002 10 91 |
876387-05-2 |
teplizumab |
|
3002 10 91 |
918127-53-4 |
tigatuzumab |
|
3002 10 91 |
745013-59-6 |
tremelimumab |
|
3002 10 91 |
339986-90-2 |
tucotuzumab celmoleukin |
|
3002 10 91 |
728917-18-8 |
veltuzumab |
|
3002 10 91 |
896731-82-1 |
conatumumab |
|
3002 10 91 |
892553-42-3 |
etaracizumab |
|
3002 10 91 |
944548-38-3 |
foravirumab |
|
3002 10 91 |
944548-37-2 |
rafivirumab |
|
3002 10 91 |
880266-57-9 |
tanezumab |
|
3002 10 91 |
815610-63-0 |
ustekinumab |
|
3002 10 95 |
862111-32-8 |
aflibercept |
|
3002 10 95 |
845264-92-8 |
atacicept |
|
3002 10 95 |
909110-25-4 |
baminercept |
|
3002 10 95 |
9001-27-8 |
beroctocog alfa |
|
3002 10 95 |
879555-13-2 |
epoetin kappa |
|
3002 10 95 |
762263-14-9 |
epoetin theta |
|
3002 10 95 |
501081-76-1 |
rilonacept |
|
3002 10 95 |
267639-76-9 |
romiplostim |
|
3002 10 95 |
869858-13-9 |
thrombin alfa |
|
3002 10 95 |
897936-89-9 |
vatreptacog alfa (attivat) |
|
3002 10 95 |
472960-22-8 |
albinterferon alfa-2b |
|
3002 10 95 |
869881-54-9 |
briobacept |
|
3002 10 95 |
606138-08-3 |
catridecacog |
|
3002 10 95 |
716840-32-3 |
denenicokin |
|
3002 10 95 |
931101-84-7 |
troplasminogen alfa |
|
3002 10 99 |
934216-54-3 |
alacizumab pegol |
|
3002 20 00 |
181477-43-0 |
disomotide |
|
3002 20 00 |
181477-91-8 |
ovemotide |
|
3002 20 00 |
915019-08-8 |
tertomotide |
|
3002 20 00 |
295371-00-5 |
verpasep caltespen |
|
3002 90 90 |
473553-86-5 |
alferminogene tadenovec |
|
3002 90 90 |
929881-05-0 |
alipogene tiparvovec |
|
3002 90 90 |
600735-73-7 |
contusugene ladenovec |
|
3002 90 90 |
851199-59-2 |
linaclotide |
|
3002 90 90 |
898830-54-1 |
sitimagene ceradenovec |
|
3002 90 90 |
721946-42-5 |
transferrin aldifitox |
|
3507 90 90 |
9026-00-0 |
bucelipase alfa |
|
3507 90 90 |
885051-90-1 |
pegloticase |
|
3507 90 90 |
884604-91-5 |
velaglucerase alfa |
|
3911 90 99 |
892497-01-7 |
azoximer bromide |
ANNESS II
Lista ta' prefissi u suffissi li, f’kombinazzjoni mal-INNs tal-Anness 3 għall-Anness I għar-Regolament (KEE) Nru 2658/87, jiddeskrivu l-imluħa, l-esteri jew l-idrati ta' INNs; dawn l-imluħa, l-esteri u l-idrati ma jkollhomx dazju fuqhom, bil-kondizzjoni li dawn ikunu klassifikabbli fl-istess subintestatura tas-SA ta' sitt ċifri bħall-INN korrespondenti
Ir-referenzi għal “Ismijiet Komuni Internazzjonali (INN) għal sustanzi farmaċewtiċi, ismijiet għal radikali u gruppi, lista eżawrjenti 2004” huma sostitwiti b’ “Ismijiet Komuni Internazzjonali (INN) għal sustanzi farmaċewtiċi, ismijiet għal radikali, gruppi u oħrajn, lista eżawrjenti 2007”.
Il-prefissi jew suffissi li ġejjin għandhom jiżdiedu mal-lista inkluża fl-Anness 4 għall-Anness I għar-Regolament (KEE) Nru 2658/87:
|
Prefiss jew suffiss ippreferut |
Sinonimu |
Isem sistematiku meta differenti |
|
alanetil (INNRG) |
|
[(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN) |
|
alaninate (INNRG) |
|
L-alaninate (INNCN) |
|
alapivoxil (INNRG) |
|
L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl (INNCN) |
|
aldifitox (INNRG) |
|
(4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl u li jifforma derivattiv ta' N-benzoyl ta' grupp ta' amine primarju ta' tossin tad-difterja [550-L-phenylalanine] minn Corynebacterium diphtheriae-(26-560)-peptide (INNCN) |
|
besudotox (INNRG) |
|
Proteina ta' fużjoni ta' L-lysyl-L-alanyl-L-serylglycylglycine (linker) b’des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoxin A (Pseudomonas aeruginosa)-(251-613)-peptide (tossina b’reġjun IA u bl-ewwel 16-il residwu ta' reġjun IB imħassrin) (INNCN) |
|
ceribate (INNRG) |
|
rac-2,3-dihydroxypropyl carbonate (ester) (INNCN) |
|
cipecilate (INNRG) |
|
cyclohexanecarboxylate (ester), cyclopropanecarboxylate (ester) (INNCN) |
|
dalanated (INNRG) |
|
des-B30-alanine (INNCN) |
|
enacarbil (INNRG) |
|
{rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN) |
|
estafenatox (INNRG) |
|
Proteina ta' fużjoni glycylglycyl-L-proline (linker) b’enterotossina tip A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotossina tip E (Staphylococcus aureus)-(32-230)-peptide (superantigen sintetiku SEA/E-120) (INNCN) |
|
etexilate (INNRG) |
|
ethyl, (hexyloxy)carbonyl |
|
fosamil (INNRG) |
|
phosphono (INNCN) |
|
glucuronide (INNRG) |
|
β-D-glucopyranosiduronic acid [oside] (INNCN) |
|
medocaril (INNRG) |
|
[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN) |
|
paptox (INNRG) |
|
protein PAP (antivirali Phytolacca americana) (INNCN) |
|
placarbil (INNRG) |
|
(R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN) |
L-isem sistematiku tal-prefiss jew suffiss li ġej huwa emendat kif ġej:
|
Prefiss jew suffiss ippreferut |
Sinonimu |
Isem sistematiku meta differenti |
|
aritox (INNRG) |
|
katina ta' ricin A (INNCN) |
ANNESS III
Lista ta’ intermedji farmaċewtiċi, jiġifieri komposti użati għall-manifattura ta’ prodotti farmaċewtiċi lesti, li għandhom jiżdiedu mal-lista ta’ prodotti li jirċievu trattament mingħajr dazju inkluża fl-Anness 6 għall-Anness I għar-Regolament (KEE) Nru 2658/87
|
Kodiċi NM |
CAS RN |
Isem |
|
2843 29 00 |
22199-08-2 |
[4-amino-N-(pyrimidin-2(1H)-ylidene-κN1)benzenesulfonamidato-κO]silver |
|
2905 39 95 |
281214-27-5 |
(2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-methylbenzenesulfonate) |
|
2905 59 98 |
441002-17-1 |
4-chlorobutyl 2-nitrobenzenesulfonate |
|
2909 30 90 |
92878-95-0 |
2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene |
|
2909 30 |
503070-57-3 |
2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-dichlorobenzene |
|
2909 30 |
461432-23-5 |
4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether |
|
2909 49 80 |
185954-75-0 |
(3R)-3-methoxydecan-1-ol |
|
2909 49 80 |
85309-91-7 |
2-[(2,6-dichlorobenzyl)oxy]ethanol |
|
2909 49 80 |
160969-03-9 |
2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate |
|
2909 50 00 |
167145-13-3 |
2-[2-(3-methoxyphenyl)ethyl]phenol |
|
2910 20 00 |
15448-47-2 |
(2R)-2-methyloxirane |
|
2910 90 00 |
62600-71-9 |
(2R)-2-(3-chlorophenyl)oxirane |
|
2910 90 00 |
702687-42-1 |
(2R)-2-[(5-bromo-2,3-difluorophenoxy)methyl]oxirane |
|
2910 90 00 |
683276-64-4 |
[(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzenesulfonate |
|
2913 00 00 |
90035-34-0 |
4′-(trifluoromethyl)biphenyl-4-carbaldehyde |
|
2914 40 90 |
17752-16-8 |
(3β)-3-hydroxycholest-5-en-24-one |
|
2914 50 00 |
974-23-2 |
(3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one |
|
2914 70 00 |
13054-81-4 |
4-chloro-heptane-3,5-dione |
|
2914 70 00 |
10226-30-9 |
6-chlorohexan-2-one |
|
2915 60 90 |
53064-79-2 |
iodomethyl pivalate |
|
2915 90 00 |
22328-90-1 |
(3R)-3-methylhexanoic acid |
|
2915 90 00 |
1069-66-5 |
sodium 2-propylpentanoate |
|
2916 20 00 |
211515-46-7 |
1-(2-ethylbutyl)cyclohexanecarbonyl chloride |
|
2916 20 00 |
381209-09-2 |
1-(2-ethylbutyl)cyclohexanecarboxylic acid |
|
2916 20 00 |
7077-05-6 |
trans-4-(propan-2-yl)cyclohexanecarboxylic acid |
|
2916 39 00 |
21900-39-0 |
5-fluoro-2-methylbenzoyl chloride |
|
2916 39 00 |
17625-03-5 |
sodium hydrogen 3-sulfonatobenzoate |
|
2917 19 90 |
76-72-2 |
diethyl ethyl pentan-2-yl)propanedioate |
|
2918 29 00 |
376592-58-4 |
5′-chloro-2′-hydroxy-3′-nitrobiphenyl-3-carboxylic acid |
|
2918 99 90 |
709031-28-7 |
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid |
|
2918 99 90 |
35480-52-5 |
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid |
|
2918 99 90 |
4651-67-6 |
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid |
|
2918 99 90 |
52179-28-9 |
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate |
|
2918 99 90 |
530141-60-7 |
methyl 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoate |
|
2920 90 10 |
91526-18-0 |
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one |
|
2921 49 00 |
334477-60-0 |
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-methylethanamine |
|
2921 49 00 |
376608-71-8 |
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate |
|
2921 49 00 |
1034457-07-2 |
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride |
|
2921 49 00 |
945717-05-5 |
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride |
|
2921 49 00 |
89-97-4 |
2-chlorobenzylamine |
|
2921 49 00 |
945717-43-1 |
N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine |
|
2921 51 90 |
150812-21-8 |
N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine |
|
2922 19 85 |
1035455-90-3 |
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}propan-2-ol hydrochloride |
|
2922 19 85 |
0-00-0 |
[2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride |
|
2922 19 85 |
133-51-7 |
antimonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:1) |
|
2922 19 85 |
1035455-87-8 |
ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)prop-2-enoate hydrochloride |
|
2922 19 85 |
702686-97-3 |
ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)propanoate hydrochloride |
|
2922 29 00 |
20059-73-8 |
2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine |
|
2922 49 85 |
848133-35-7 |
(2E)-4-(dimethylamino)but-2-enoic acid hydrochloride |
|
2922 49 85 |
610300-07-7 |
(3S,5R)-3-amino-5-methyloctanoic acid |
|
2922 49 85 |
610300-00-0 |
(3S,5R)-3-amino-5-methyloctanoic acid hydrochloride |
|
2922 49 85 |
143785-86-8 |
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid |
|
2922 49 85 |
848949-85-9 |
4-fluoro-L-leucine – ethyl hydrogen sulfate (1:1) |
|
2922 49 85 |
39068-93-4 |
methyl 2-(dimethylamino)-2-phenylbutanoate |
|
2922 49 85 |
168619-25-8 |
methyl 3′-aminobiphenyl-3-carboxylate |
|
2922 49 85 |
82834-12-6 |
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine |
|
2922 49 85 |
94133-84-3 |
sodium 2-amino-2-phenylbutanoate |
|
2922 50 00 |
503070-58-4 |
triphenylacetic acid – 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) |
|
2924 19 00 |
62009-47-6 |
2-aminomalonamide |
|
2924 19 00 |
7355-58-0 |
N-(2-chloroethyl)acetamide |
|
2924 29 98 |
361442-00-4 |
{2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid |
|
2924 29 98 |
266993-72-0 |
2,3-diaminobenzamide dihydrochloride |
|
2924 29 98 |
168080-49-7 |
2-chloro-4-{[(5-fluoro-2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
317374-08-6 |
2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
143785-84-6 |
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid |
|
2924 29 98 |
143785-87-9 |
4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid |
|
2924 29 98 |
108166-22-9 |
4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |
|
2924 29 98 |
150812-23-0 |
ethyl {4-[(4-fluorobenzyl)amino]-2-nitrophenyl}carbamate |
|
2924 29 98 |
22316-45-6 |
ethyl 3-[(5-chloro-2-nitrophenyl)(phenyl)amino]-3-oxopropanoate |
|
2924 29 98 |
316173-29-2 |
methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxylate |
|
2924 29 98 |
1142-20-7 |
N-benzyloxycarbonyl-L-alanine |
|
2924 29 98 |
84996-93-0 |
N-cyclohexyl-5-hydroxypentanamide |
|
2924 29 98 |
579494-66-9 |
propyl {4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetate |
|
2925 19 95 |
265136-65-0 |
ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoate |
|
2926 90 95 |
855425-38-6 |
1-(2-ethylbutyl)cyclohexanecarbonitrile |
|
2926 90 95 |
846023-24-3 |
2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide |
|
2926 90 95 |
591769-05-0 |
3-cyclopentylprop-2-enenitrile |
|
2926 90 95 |
20099-89-2 |
4-(bromoacetyl)benzonitrile |
|
2926 90 95 |
474554-45-5 |
4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile |
|
2926 90 95 |
79370-78-8 |
5-hydroxybenzene-1,3-dicarbonitrile |
|
2926 90 95 |
139481-28-0 |
methyl 2-{[(2′-cyanobiphenyl-4-yl)methyl]amino}-3-nitrobenzoate |
|
2928 00 90 |
860035-10-5 |
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate |
|
2928 00 90 |
910656-45-0 |
2-hydroxy-2-(trifluoromethyl)butanehydrazide |
|
2928 00 90 |
95759-10-7 |
4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid |
|
2928 00 90 |
473927-63-8 |
ethyl (2Z)-chloro[2-(4-methoxyphenyl)hydrazinylidene]ethanoate |
|
2928 00 90 |
158671-29-5 |
N,2-dihydroxy-4-methylbenzamide |
|
2928 00 90 |
84080-68-2 |
tert-butyl (2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |
|
2928 00 90 |
268544-50-9 |
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |
|
2930 90 99 |
13459-62-6 |
{2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid |
|
2930 90 99 |
211513-21-2 |
1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide |
|
2930 90 99 |
860035-07-0 |
1-{[(methylsulfanyl)carbonyl]oxy}ethyl 2-methylpropanoate |
|
2930 90 99 |
893407-18-6 |
2,2,2-trifluoro-1-[4′-(methylsulfonyl)biphenyl-4-yl]ethanone |
|
2930 90 99 |
60759-00-4 |
3,4-diethoxybenzenecarbothioamide |
|
2930 90 99 |
21048-05-5 |
N-methylbenzenecarbothiohydrazide |
|
2931 00 99 |
13682-94-5 |
(2-bromoethenyl)(trimethyl)silane |
|
2931 00 99 |
914922-89-7 |
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide |
|
2931 00 99 |
914922-88-6 |
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamide |
|
2931 00 99 |
871355-80-5 |
(4R)-2-bromo-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzenesulfonate |
|
2931 00 99 |
89694-48-4 |
(5-chloro-2-methoxyphenyl)boronic acid |
|
2931 00 99 |
701278-08-2 |
[(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol |
|
2931 00 99 |
701278-09-3 |
{(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol |
|
2931 00 99 |
796967-18-5 |
1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea |
|
2931 00 99 |
172732-52-4 |
2-(1,3,2-dioxaborinan-2-yl)benzonitrile |
|
2931 00 99 |
185411-12-5 |
methyl 3-(trimethylsilyl)pent-4-enoate |
|
2932 19 00 |
253128-10-8 |
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol |
|
2932 19 00 |
441045-17-6 |
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one methanesulfonate |
|
2932 29 85 |
916069-80-2 |
(4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one |
|
2932 29 85 |
63106-93-4 |
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
|
2932 29 85 |
7734-80-7 |
2-oxo-2H-chromene-6-carboxylic acid |
|
2932 29 85 |
0-00-0 |
4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-one |
|
2932 29 85 |
947408-91-5 |
6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-one |
|
2932 29 85 |
947408-90-4 |
6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-one |
|
2932 99 00 |
452342-08-4 |
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol |
|
2932 99 00 |
99541-23-8 |
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate |
|
2932 99 00 |
461432-25-7 |
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol |
|
2932 99 00 |
196597-79-2 |
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile |
|
2932 99 00 2911 00 00 |
3308-94-9 |
2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane |
|
2932 99 00 |
274693-53-7 |
[(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamate |
|
2932 99 00 |
185954-98-7 |
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose 1-(dihydrogen phosphate) tetrasodium salt |
|
2932 99 00 |
136172-58-2 |
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose |
|
2932 99 00 |
196597-80-5 |
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanamine hydrochloride |
|
2932 99 00 |
666860-59-9 |
2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamate |
|
2932 99 00 |
117661-72-0 |
5-(chloromethyl)-6-methyl-1,3-benzodioxole |
|
2932 99 00 |
959624-24-9 |
6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol |
|
2932 99 00 |
960404-59-5 |
but-2-yne-1,4-diol – methyl 1-C-[4-chloro-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranoside (1:1) |
|
2932 99 00 |
15826-37-6 |
disodium 5,5′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate) |
|
2932 99 00 |
204254-84-2 |
ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate |
|
2932 99 00 |
99541-26-1 |
methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate |
|
2932 99 00 |
114869-97-5 |
methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranoside |
|
2933 19 90 |
1035677-60-1 |
(4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 2,3-dihydroxybutanedioate |
|
2933 19 90 |
18048-64-1 |
2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one |
|
2933 19 90 |
1035675-24-1 |
3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide |
|
2933 19 90 |
1028026-83-6 |
5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one |
|
2933 19 90 |
473921-12-9 |
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile |
|
2933 29 90 |
65902-59-2 |
2-bromo-4-nitro-1H-imidazole |
|
2933 29 90 |
57531-37-0 |
2-chloro-4-nitro-1H-imidazole |
|
2933 29 90 |
1000164-35-1 |
3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycine |
|
2933 29 90 |
152074-97-0 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine |
|
2933 29 90 |
781666-30-6 |
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine tetraacetate |
|
2933 29 90 |
451470-33-0 |
methyl 3′-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylate |
|
2933 39 99 |
925978-49-0 |
(+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octane |
|
2933 39 99 |
876170-44-4 |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
|
2933 39 99 |
741705-70-4 |
(2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid hydrochloride |
|
2933 39 99 |
414910-13-7 |
(2S)-hydroxy(phenyl)ethanoic acid – (2R)-2-(4-fluoro-2-methylphenyl)piperidin-4-one (1:1) |
|
2933 39 99 |
0-00-0 |
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole 4-methylbenzenesulfonate |
|
2933 39 99 |
370882-57-8 |
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole dihydrochloride |
|
2933 39 99 |
334618-23-4 |
(3R)-piperidin-3-amine dihydrochloride |
|
2933 39 99 |
1062580-52-2 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
|
2933 39 99 |
27262-47-1 |
(S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
|
2933 39 99 |
105812-81-5 |
[(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol |
|
2933 39 99 |
876068-51-8 |
[(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-yl)pyrrolidin-3-yl]methanol |
|
2933 39 99 |
871022-14-9 |
1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutanecarboxylic acid |
|
2933 39 99 |
5421-92-1 |
1-(pyridin-4-yl)pyridinium chloride hydrochloride |
|
2933 39 99 |
272776-12-2 |
1,1′-binaphthalene-2,2′-diol – 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole (1:1) |
|
2933 39 99 |
871022-19-4 |
1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylic acid |
|
2933 39 99 |
3613-73-8 |
2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
|
2933 39 99 |
179687-79-7 |
2-[(2-chloro-4-nitrophenoxy)methyl]pyridine |
|
2933 39 99 |
122321-04-4 |
2-[methyl(pyridin-2-yl)amino]ethanol |
|
2933 39 99 |
945405-37-8 |
2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2,3-dihydroxybutanedioate |
|
2933 39 99 |
936637-40-0 |
3,3′-piperidine-1,4-diyldipropan-1-ol 4-methylbenzenesulfonate |
|
2933 39 99 |
88150-62-3 |
3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
|
2933 39 99 |
84100-54-9 |
4-(ethylamino)piperidine-4-carboxamide |
|
2933 39 99 |
873546-30-6 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis(N′-hydroxybenzenecarboximidamide) |
|
2933 39 99 |
873546-74-8 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis[N′-(acetyloxy)benzenecarboximidamide] |
|
2933 39 99 |
873546-38-4 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzenecarboximidamide trihydrochloride pentahydrate |
|
2933 39 99 |
873546-80-6 |
4,4′-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzonitrile |
|
2933 39 99 |
78750-61-5 |
4-[(3-nitropyridin-2-yl)amino]phenol |
|
2933 39 99 |
866109-93-5 |
4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzenesulfonate |
|
2933 39 99 |
927889-51-8 |
4-bromo-2,6-diethylpyridine 4-methylbenzenesulfonate |
|
2933 39 99 |
691882-47-0 |
4-hydroxybenzoic acid – (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amine (1:1) |
|
2933 39 99 |
876068-46-1 |
5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine |
|
2933 39 99 |
1072-98-6 |
5-chloropyridin-2-amine |
|
2933 39 99 |
298692-34-9 |
6-(chloroacetyl)pyridine-2-carboxylic acid |
|
2933 39 99 |
550349-58-1 |
7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxamide |
|
2933 39 99 |
414909-98-1 |
benzyl 2-(4-fluoro-2-methylphenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate |
|
2933 39 99 |
56880-11-6 |
ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetate |
|
2933 39 99 |
548797-97-3 |
N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamide |
|
2933 39 99 |
0-00-0 |
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride |
|
2933 39 99 |
329003-65-8 |
sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate hemipentahydrate |
|
2933 49 10 |
417716-92-8 |
4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide methanesulfonate |
|
2933 49 90 |
503291-53-0 |
2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylate 4-methylbenzenesulfonate |
|
2933 49 90 |
103733-32-0 |
benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride |
|
2933 49 90 |
503293-98-9 |
(3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinoline-3-carboxylic acid |
|
2933 49 90 |
503290-66-2 |
(3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylic acid hydrochloride |
|
2933 49 90 |
134388-95-7 |
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid – (1R)-1-phenylethanamine (1:1) |
|
2933 49 90 |
868210-14-4 |
4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutanoic acid |
|
2933 49 90 |
00-00-0 |
methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoate hydrochloride |
|
2933 49 90 |
848133-76-6 |
N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide |
|
2933 59 95 |
869490-23-3 |
(3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone |
|
2933 59 95 |
941685-40-1 |
(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941678-49-5 |
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941685-41-2 |
(3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
957187-34-7 |
[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetic acid |
|
2933 59 95 |
356058-42-9 |
{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid |
|
2933 59 95 |
0-00-0 |
2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic acid – ethyl [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1) |
|
2933 59 95 |
90213-66-4 |
2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
3934-20-1 |
2,4-dichloropyrimidine |
|
2933 59 95 |
451487-18-6 |
2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one |
|
2933 59 95 |
865758-96-9 |
2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile |
|
2933 59 95 |
934815-71-1 |
2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic acid phosphate |
|
2933 59 95 |
722543-31-9 |
2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate |
|
2933 59 95 |
1032066-96-8 |
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one – methanesulfonate (2:1) |
|
2933 59 95 |
540737-29-9 |
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate |
|
2933 59 95 |
1137917-12-4 |
3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoic acid – 1,4-diazabicyclo[2.2.2]octane (2:1) |
|
2933 59 95 |
941685-39-8 |
3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
2933 59 95 |
941685-27-4 |
4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
1780-26-3 |
4,6-dichloro-2-methylpyrimidine |
|
2933 59 95 |
145783-14-8 |
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine |
|
2933 59 95 |
3680-69-1 |
4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
|
2933 59 95 |
61379-64-4 |
4-cyclopentylpiperazin-1-amine |
|
2933 59 95 |
55112-42-0 |
4-methylpiperazine-1-carbonyl chloride hydrochloride |
|
2933 59 95 |
0-00-0 |
5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile – (2E)-but-2-enedioate (2:1) hydrate |
|
2933 59 95 |
55293-96-4 |
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde |
|
2933 59 95 |
179688-01-8 |
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one |
|
2933 59 95 |
444731-74-2 |
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
|
2933 59 95 |
0-00-0 |
N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidine-5-carboxamide |
|
2933 79 00 |
586414-48-4 |
(-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide |
|
2933 79 00 |
425663-71-4 |
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride |
|
2933 79 00 |
813452-14-1 |
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one dihydrochloride |
|
2933 79 00 |
5162-90-3 |
3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine |
|
2933 79 00 |
536760-29-9 |
3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |
|
2933 79 00 |
4876-10-2 |
4-(bromomethyl)quinolin-2(1H)-one |
|
2933 79 00 |
5057-12-5 |
4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione |
|
2933 79 00 |
54197-66-9 |
6-hydroxy-3,4-dihydroquinolin-2(1H)-one |
|
2933 79 00 |
22246-18-0 |
7-hydroxy-3,4-dihydroquinolin-2(1H)-one |
|
2933 79 00 |
536759-91-8 |
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
2933 79 00 |
503614-91-3 |
ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
2933 79 00 |
586379-61-5 |
methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate |
|
2933 99 80 |
709031-45-8 |
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate |
|
2933 99 80 |
649735-46-6 |
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol |
|
2933 99 80 |
51077-14-6 |
(2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid |
|
2933 99 80 |
631916-97-7 |
(2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide – benzenesulphonic acid (1:1) |
|
2933 99 80 |
80875-98-5 |
(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid |
|
2933 99 80 |
948846-40-0 |
(2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid – ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:1) |
|
2933 99 80 |
1000164-36-2 |
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-oic acid |
|
2933 99 80 |
22162-51-2 |
1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde |
|
2933 99 80 |
35681-40-4 |
1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one |
|
2933 99 80 |
166170-15-6 |
1-(tert-butoxycarbonyl)-2-methyl-D-proline |
|
2933 99 80 |
796967-16-3 |
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea |
|
2933 99 80 |
0-00-0 |
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride |
|
2933 99 80 |
444731-72-0 |
2,3-dimethyl-2H-indazol-6-amine |
|
2933 99 80 |
19686-05-6 |
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
|
2933 99 80 |
912444-00-9 |
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide |
|
2933 99 80 |
912445-36-4 |
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride |
|
2933 99 80 |
163457-23-6 |
3,3-difluoropyrrolidine hydrochloride |
|
2933 99 80 |
239463-85-5 |
3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (2R,3R)-2,3-dihydroxybutanedioate |
|
2933 99 80 |
55321-99-8 |
3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
952490-01-6 |
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |
|
2933 99 80 |
942436-93-3 |
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
942437-37-8 |
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide |
|
2933 99 80 |
288385-88-6 |
4-fluoro-2-methyl-1H-indol-5-ol |
|
2933 99 80 |
503293-47-8 |
5-(2-chloro-6-fluorophenyl)-2H-tetrazole |
|
2933 99 80 |
73963-42-5 |
5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole |
|
2933 99 80 |
606143-52-6 |
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
|
2933 99 80 |
0-00-0 |
5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide |
|
2933 99 80 |
872206-47-8 |
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |
|
2933 99 80 |
259793-88-9 |
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide |
|
2933 99 80 |
1137606-74-6 |
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile – N-cyclohexylcyclohexanamine (1:1) |
|
2933 99 80 |
261953-36-0 |
6-iodo-1H-indazole |
|
2933 99 80 |
80076-47-7 |
8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid |
|
2933 99 80 |
52602-39-8 |
9H-carbazol-4-ol |
|
2933 99 80 |
145641-35-6 |
benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride |
|
2933 99 80 |
87269-87-2 |
benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride |
|
2933 99 80 |
1012065-72-3 |
ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate |
|
2933 99 80 |
131707-24-9 |
ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate |
|
2933 99 80 |
105152-95-2 |
ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate |
|
2933 99 80 |
139481-44-0 |
methyl 1-[(2′-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate |
|
2933 99 80 |
0-00-0 |
methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate |
|
2933 99 80 |
21688-11-9 |
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide |
|
2933 99 80 |
361440-67-7 |
tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate |
|
2933 99 80 |
709031-38-9 |
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate |
|
2933 99 80 |
709031-43-6 |
tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate |
|
2933 49 90 |
936359-25-0 |
methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoate |
|
2934 10 00 |
110130-88-6 |
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid |
|
2934 10 00 |
68672-66-2 |
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid |
|
2934 10 00 |
291536-35-1 |
(5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione |
|
2934 10 00 |
302964-24-5 |
2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide |
|
2934 10 00 |
866920-24-3 |
3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one |
|
2934 10 00 |
752253-39-7 |
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine |
|
2934 10 00 |
914361-45-8 |
L-lysine – {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy}methyl dihydrogen phosphate – ethanol (1:1:1) |
|
2934 10 00 |
302964-08-5 |
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide |
|
2934 10 00 |
127660-04-2 |
sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate |
|
2934 99 90 |
17381-54-3 |
(1-benzothiophen-5-yl)acetic acid |
|
2934 99 90 |
630100-90-2 |
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol |
|
2934 99 90 |
220099-91-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] |
|
2934 99 90 |
220100-81-2 |
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate |
|
2934 99 90 |
161599-46-8 |
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate |
|
2934 99 90 |
690270-65-6 |
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride |
|
2934 99 90 |
265121-04-8 |
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:2) |
|
2934 99 90 |
163680-80-6 |
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
2934 99 90 |
132335-46-7 |
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
|
2934 99 90 |
133413-70-4 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone |
|
2934 99 90 |
503068-36-8 |
(5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |
|
2934 99 90 |
452339-73-0 |
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |
|
2934 99 90 |
877130-28-4 |
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one |
|
2934 99 90 |
132335-44-5 |
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol |
|
2934 99 90 |
812647-80-6 |
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate |
|
2934 99 90 |
00-00-0 |
1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one |
|
2934 99 90 |
1029716-44-6 |
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
|
2934 99 90 |
165172-60-1 |
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione – 1-methylpyrrolidin-2-one (1:1) |
|
2934 99 90 |
519187-97-4 |
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butenedioate (1:1) |
|
2934 99 90 |
127000-90-2 |
1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole |
|
2934 99 90 |
710281-33-7 |
2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic acid |
|
2934 99 90 |
96803-30-4 |
2-(1-benzothiophen-5-yl)ethanol |
|
2934 99 90 |
913695-00-8 |
2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1Hbenzimidazole, melħ tas-sodju (1:1) |
|
2934 99 90 |
376608-74-1 |
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol |
|
2934 99 90 |
474554-48-8 |
2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone |
|
2934 99 90 |
530141-72-1 |
3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid |
|
2934 99 90 |
519188-55-7 |
3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-one |
|
2934 99 90 |
519188-42-2 |
3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid |
|
2934 99 90 |
753015-42-8 |
3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine |
|
2934 99 90 |
26638-53-9 |
3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |
|
2934 99 90 |
499785-81-8 |
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
356782-84-8 |
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |
|
2934 99 90 |
6504-57-0 |
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate |
|
2934 99 90 |
871484-32-1 |
4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide |
|
2934 99 90 |
166964-09-6 |
4-chloro-3-methyl-1,2-oxazol-5-amine |
|
2934 99 90 |
655233-39-3 |
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride |
|
2920 90 85 |
89729-09-9 |
5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide |
|
2934 99 90 |
388082-75-5 |
5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde – 4-methylbenzenesulfonate (1:1) |
|
2934 99 90 |
4923-87-9 |
5-bromo-1-benzothiophene |
|
2934 99 90 |
947408-95-9 |
6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one |
|
2934 99 90 |
947408-94-8 |
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one |
|
2934 99 90 |
67978-05-6 |
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate |
|
2934 99 90 |
1001859-46-6 |
DNA (synthetic plasmid vector pCORhuman interferon beta signal peptide fusion protein bi 21-154-human acidic fibroblast growth factor-specifying) |
|
2934 99 90 |
665058-78-6 |
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T) |
|
2934 99 90 |
923591-06-4 |
methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate |
|
2934 99 90 |
59337-92-7 |
methyl 3-(chlorosulfonyl)thiophene-2-carboxylate |
|
2934 99 90 |
947409-01-0 |
methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)methoxy]phenyl]propionate |
|
2934 99 90 |
85006-31-1 |
methyl 3-amino-4-methylthiophene-2-carboxylate |
|
2934 99 90 |
893428-72-3 |
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine – (2E)-2-butenedioate (1:2) |
|
2934 99 90 |
390800-88-1 |
N,N′,N′′-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide |
|
2934 99 90 |
112913-94-7 |
N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide |
|
2934 99 90 |
120788-03-6 |
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate |
|
2935 00 90 |
1198178-65-2 |
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate |
|
2935 00 90 |
39570-96-2 |
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide |
|
2935 00 90 |
24310-36-9 |
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |
|
2935 00 90 |
0-00-0 |
2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate |
|
2935 00 90 |
941690-55-7 |
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |
|
2935 00 90 |
6973-09-7 |
5-amino-2-methylbenzenesulfonamide |
|
2935 00 90 |
193686-76-9 |
7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |
|
2935 00 90 |
123664-84-6 |
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide |
|
2935 00 90 |
149457-03-4 |
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide |
|
2935 00 90 |
149456-98-4 |
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide |
|
2935 00 90 |
141450-48-8 |
N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride |
|
2935 00 90 |
289042-10-0 |
N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethanesulfonamide |
|
2939 99 00 |
7689-03-4 |
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
|
2939 99 00 |
477-29-2 |
colchicoside |
|
2940 00 00 |
604-69-3 |
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose |
|
2940 00 00 |
647834-15-9 |
2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside |
|
2941 90 00 |
76610-92-9 |
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
3907 20 99 |
913976-27-9 |
poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 21′N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6′→15′) bis(disulfide) |
ANNESS IV
Lista ta' intermedji farmaċewtiċi, jiġifieri komposti użati għall-manifattura ta' prodotti farmaċewtiċi lesti, li għandhom jiġu rtirati mil-lista ta' prodotti li jirċievu trattament mingħajr dazju inkluża fl-Anness 6 għall-Anness I għar-Regolament (KEE) Nru 2658/87 minħabba t-trasferiment tagħhom għal-lista ta' prodotti li jirċievu trattament mingħajr dazju inkluża fl-Anness 3 għall-Anness I għar-Regolament (KEE) Nru 2658/87
|
Kodiċi NM |
CAS RN |
Isem |
|
2915 39 00 2937 29 00 |
7753-60-8 |
17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl acetate ara anecortave (INN) |
|
2920 90 85 |
163133-43-5 |
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate ara naproxcinod (INN) |
|
2924 29 98 |
194085-75-1 |
2-(2-chlorophenyl)-2-hydroxyethyl carbamate ara carisbamate (INN) |
|
2933 39 99 |
103129-82-4 |
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate ara levamlodipine (INN) |
|
2933 39 99 |
319460-85-0 |
N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide ara axitinib (INN) |
|
2934 10 00 |
302962-49-8 |
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazole-5-carboxamide ara dasatinib (INN) |
|
2934 99 90 |
143491-57-0 |
(2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one ara emtricitabine(INN) |
|
2934 99 90 |
98819-76-2 |
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine ara esreboxetine (INN) |
|
2934 99 90 |
475479-34-6 |
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid ara aleglitazar (INN) |
|
2934 99 90 |
377727-87-2 |
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine ara preladenant (INN) |
|
2934 99 90 |
189003-92-7 |
2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamide ara trelanserin (INN) |
|
2934 99 90 |
134379-77-4 |
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one ara dexelvucitabine (INN) |
|
2934 99 90 |
518048-05-0 |
potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olate ara raltegravir (INN) |
|
2935 00 90 |
170569-88-7 |
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide ara mavacoxib (INN) |
|
2935 00 90 |
186497-07-4 |
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide ara zibotentan (INN) |
